Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST
暂无分享,去创建一个
A Worth | H Cowie | A Marcomini | M Whelan | A. Bartoňová | G. Pojana | A. Marcomini | L. Juillerat-Jeanneret | A. Collins | P. Papazafiri | M. Whelan | M. Saunders | J. Castell | M. Dusinska | R. Handy | S. Correia Carreira | L. Walker | H. Cowie | L. Tran | L. Gombau | T. Palosaari | M. Kuricová | C. Housiadas | B. Ross | Z. Kováčiková | M. Harju | Z. Magdolénová | G. Harris | T Palosaari | A R Collins | M Dusinska | Z Magdolenova | A Bartonova | M Harju | L Tran | B Ross | F Marano | S Boland | M Saunders | E Burello | C Housiadas | M Pilou | K Volkovova | J Tulinska | A Kazimirova | M Barancokova | K Sebekova | M Hurbankova | Z Kovacikova | L Gombau | J Castell | G Pojana | D Bilanicova | D Vallotto | L Juillerat-Jeanneret | L E Knudsen | B Halamoda Kenzaoui | S Correia Carreira | L M Fjellsbø | A Huk | R Handy | L Walker | M Drlickova | R Guadagnini | G Harris | E S Heimstad | M Kuricova | A Liskova | A Milcamps | E Neubauerova | P Papazafiri | M S Poulsen | E Runden-Pran | M Staruchova | K. Volkovová | A. Milcamps | E. Burello | A. Huk | R. Guadagnini | M. Pilou | Andrew Paul Worth | K. Šebeková | J. Tulinská | A. Líšková | M. Staruchová | M. Hurbánková | E. Neubauerová | A. Kažimírová | M. Barančoková | D. Vallotto | E. Rundén-Pran | D. Bilaničová | M. Poulsen | B. Halamoda Kenzaoui | M. Drličková | S. Boland | F. Marano | L. Knudsen | L. Fjellsbø | E. Heimstad
[1] Maria Dusinska,et al. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles , 2014, Nanotoxicology.
[2] Julie W. Fitzpatrick,et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.
[3] David B Warheit,et al. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[4] Maria Dusinska,et al. Health effects of selected nanoparticles in vivo: liver function and hepatotoxicity following intravenous injection of titanium dioxide and Na-oleate-coated iron oxide nanoparticles in rodents , 2015, Nanotoxicology.
[5] P. Niedermann,et al. Transfer of ultrasmall iron oxide nanoparticles from human brain-derived endothelial cells to human glioblastoma cells. , 2013, ACS applied materials & interfaces.
[6] Maria Dusinska,et al. Can Standard Genotoxicity Tests be Applied to Nanoparticles? , 2012, Journal of toxicology and environmental health. Part A.
[7] H. M. Nielsen,et al. In vitro placental model optimization for nanoparticle transport studies , 2012, International journal of nanomedicine.
[8] H. Karlsson,et al. The comet assay in nanotoxicology research , 2010, Analytical and bioanalytical chemistry.
[9] Sean Callanan,et al. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] L. Medina-Kauwe,et al. Erratum: Chemotherapy targeting by DNA capture in viral protein particles (Nanomedicine (2012) 7:3 (335-352)) , 2012 .
[11] Maria Dusinska,et al. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. , 2012, Journal of environmental monitoring : JEM.
[12] K. Wittmaack,et al. Excessive delivery of nanostructured matter to submersed cells caused by rapid gravitational settling. , 2011, ACS nano.
[13] Sonja Boland,et al. Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells , 2010, Particle and Fibre Toxicology.
[14] Iseult Lynch,et al. Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. , 2011, Small.
[15] Maria Dusinska,et al. Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. , 2010, The Science of the total environment.
[16] M. Dusinska,et al. Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by the comet assay and the cytokinesis-block micronucleus assay. , 2012, Mutation research.
[17] David P. Whistler,et al. Chapter 11 , 2003, Aristotle's De Motu Animalium.
[18] S. Retterer,et al. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. , 2013, Nanoscale.
[19] Helinor Johnston,et al. Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.
[20] Maria Dusinska,et al. Toxicological aspects for nanomaterial in humans. , 2013, Methods in molecular biology.
[21] J. Castell,et al. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.
[22] Maria Dusinska,et al. Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles , 2015, Nanotoxicology.
[23] Katsuhide Fujita,et al. Reliable size determination of nanoparticles using dynamic light scattering method for in vitro toxicology assessment. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[24] M. Saunders,et al. The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST , 2015, Nanotoxicology.
[25] L. Juillerat-Jeanneret,et al. Differential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticles , 2014, International journal of nanomedicine.
[26] Pratim Biswas,et al. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies , 2009 .
[27] Sonja Boland,et al. Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells , 2015, Nanotoxicology.
[28] Martin Hassellöv,et al. Analysis and Characterization of Manufactured Nanoparticles in Aquatic Environments , 2009 .
[29] Andrew D. Maynard,et al. Nanotoxicology: Laying a Firm Foundation for Sustainable Nanotechnologies , 2007 .
[30] Michael T. Postek,et al. Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities , 2012, Nanotoxicology.
[31] P. Papazafiri,et al. Computational modeling as part of alternative testing strategies in the respiratory and cardiovascular systems: Inhaled nanoparticle dose modeling based on representative aerosol measurements and corresponding toxicological analysis , 2015, Nanotoxicology.
[32] Teresa F. Fernandes,et al. Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far? , 2012, Ecotoxicology.
[33] Andrew P Worth,et al. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles , 2011, Nanotoxicology.
[34] Stephen M. Roberts,et al. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies , 2007 .
[35] Iseult Lynch,et al. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[36] Mark R. Wiesner,et al. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment – issues and recommendations , 2011, Nanotoxicology.
[37] G. Pojana,et al. Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles , 2015, Nanotoxicology.
[38] Antonio Marcomini,et al. Effect-oriented physicochemical characterization of nanomaterials , 2007 .
[39] Guidance on Sample Preparation and Dosimetry for the Safety Testing of Manufactured Nanomaterials , 2012, OECD Series on the Safety of Manufactured Nanomaterials and other Advanced Materials.
[40] Kenneth A Dawson,et al. A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. , 2011, Nanoscale.
[41] R. Janzer,et al. Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines , 1992, In Vitro Cellular & Developmental Biology - Animal.
[42] L. Juillerat-Jeanneret,et al. Stress reaction of kidney epithelial cells to inorganic solid-core nanoparticles , 2012, Cell Biology and Toxicology.
[43] Lucienne Juillerat-Jeanneret,et al. Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. , 2012, Nanomedicine.
[44] P. Boor,et al. Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats , 2014, Nanotoxicology.
[45] L. Juillerat-Jeanneret,et al. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells , 2012, International journal of nanomedicine.
[46] Maria Dusinska,et al. Iron oxide nanoparticle toxicity testing using high-throughput analysis and high-content imaging , 2015, Nanotoxicology.
[47] Maria Dusinska,et al. Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project , 2015, Nanotoxicology.
[48] G. Daston,et al. Toxicology of nanoparticles. , 2012, Advanced drug delivery reviews.
[49] Ying Liu,et al. Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions. , 2013, Small.
[50] Iseult Lynch,et al. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices , 2011, Nanotoxicology.
[51] Iseult Lynch,et al. The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.
[52] Andrew P. Worth,et al. A rule for designing safer nanomaterials: do not interfere with the cellular redox equilibrium , 2015, Nanotoxicology.
[53] Alexandra Kroll,et al. Interference of engineered nanoparticles with in vitro toxicity assays , 2012, Archives of Toxicology.
[54] J. Castillo,et al. Critical considerations for the determination of nanoparticle number concentrations, size and number size distributions by single particle ICP-MS , 2013 .
[55] Agnes G Oomen,et al. What do we (need to) know about the kinetic properties of nanoparticles in the body? , 2007, Regulatory toxicology and pharmacology : RTP.
[56] M. Saunders,et al. Critical Evaluation of Toxicity Tests , 2012 .
[57] L. Knudsen,et al. Kinetics of silica nanoparticles in the human placenta , 2015, Nanotoxicology.
[58] G. Pojana,et al. Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model , 2015, Nanotoxicology.
[59] Lucienne Juillerat-Jeanneret,et al. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. , 2012, The Biochemical journal.
[60] Margaret Saunders,et al. Transplacental transport of nanomaterials. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[61] Iseult Lynch,et al. Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. , 2011, Nanomedicine.
[62] Maria Dusinska,et al. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests , 2015, Nanotoxicology.